DDInter948 DDInter718
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
Fenofibrate is a fibric acid derivative like [clofibrate] and [gemfibrozil]. Fenofibrate is used to treat primary hypercholesterolemia, mixed dyslipidemia, severe hypertriglyceridemia.[L8588,L8591] Fenofibrate was granted FDA approval on 31 December 1993.
Fenofibrate {u} (Compound) resembles {v} (Compound) Etofibrate
Fenofibrate {u} (Compound) treats {v} (Disease) coronary artery disease
Fenofibrate {u} (Compound) binds {v} (Gene) CYP2C8
Fenofibrate {u} (Compound) upregulates {v} (Gene) SOX2
Fenofibrate {u} (Compound) is included by {v} (Pharmacologic Class) Peroxisome Proliferator-activated Receptor alpha Agonists
Fenofibrate {u} (Compound) downregulates {v} (Gene) PSMD9
Fenofibrate {u} (Compound) causes {v} (Side Effect) Hyperhidrosis
Fenofibrate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Zafirlukast
Fenofibrate {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Insulin degludec
Fenofibrate {u} may lead to a major life threatening interaction when taken with {v} Teriflunomide
Fenofibrate (Compound) resembles Etofibrate (Compound)
Fenofibrate (Compound) treats coronary artery disease (Disease)
Fenofibrate (Compound) binds CYP2C8 (Gene)
Fenofibrate (Compound) upregulates SOX2 (Gene)
Fenofibrate (Compound) is included by Peroxisome Proliferator-activated Receptor alpha Agonists (Pharmacologic Class)
Fenofibrate (Compound) downregulates PSMD9 (Gene)
Fenofibrate (Compound) causes Hyperhidrosis (Side Effect)
Fenofibrate may cause a moderate interaction that could exacerbate diseases when taken with Zafirlukast
Fenofibrate may cause a moderate interaction that could exacerbate diseases when taken with Insulin degludec
Fenofibrate may lead to a major life threatening interaction when taken with Teriflunomide